Pfizer, Allergan Win Out With Tax Benefits
- 4 of the top 20 health-care firms in S&P 500 recorded gains
- J&J took the biggest charge, data compiled by Bloomberg show
This article is for subscribers only.
Four of the 20 biggest health-care companies in the Standard & Poor’s 500 Index saw a benefit from the tax overhaul in the fourth quarter.
The biggest gain was pharmaceutical giant Pfizer Inc. with a $11.5 billion benefit, followed by Allergan Plc with $2.78 billion, data compiled by Bloomberg shows.